跳至主要内容
临床试验/NCT07183683
NCT07183683招募中不适用

Electrical Versus Manual Stimulation of Acupuncture Points in Female Patients With Multiple Sclerosis and Neurogenic Bladder Dysfunction - A Pragmatic, Exploratory, Three-Arm, Randomized Controlled Trial Using a Mixed Methods Approach

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Incontinence Questionnaire Overactive Bladder (ICIQ-OAB)

研究概览

简要总结

Electrical vs. manual stimulation: The study compares two types of acupuncture - one using mild electrical currents and one using just manual no-needle techniques in the treatment of urinary bladder disfunction.

The study focuses on women diagnosed with multiple sclerosis (MS) who also have neurogenic bladder dysfunction - a condition where the bladder doesn't work properly due to nerve damage.

详细描述

The objective of this study is to evaluate the feasibility, therapeutic effects, and safety of (A) electrical stimulation of acupuncture points (using a TENS device) in addition to routine care, and (B) manual stimulation of acupuncture points (using acupressure) in addition to routine care, compared to (C) routine care alone (control group), in female patients with multiple sclerosis (MS) and neurogenic bladder dysfunction.

Key outcome parameters include symptoms of neurogenic bladder dysfunction assessed using standardized patient-reported outcome measures.

Moreover, a qualitative substudy will be conducted to explore the subjectively perceived effects of the study interventions and the overall feasibility of the study. This will be carried out through semi-structured interviews and analyzed using qualitative research methodology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Female patients, aged 18-60 years, with relapsing-remitting multiple sclerosis (RRMS) and an Expanded Disability Status Scale (EDSS) score ≤ 6
  • •Stable immunomodulatory MS therapy for at least 3 months prior to enrollment
  • •Presence of at least 3 out of the following 6 criteria indicative of overactive bladder dysfunction: urgency, daytime urinary frequency >10 times, nocturia >1 time per night, post-void dribbling, incontinence, or delayed initiation of micturition
  • •Participants must be willing and cognitively and linguistically capable of adhering to the study protocol, performing the study interventions, and completing the required study documentation
  • •Capacity to provide informed consent, and provision of written consent for both written and electronic data collection and participation in the study

排除标准

  • •Acute MS relapse within the last 3 months prior to individual study entry
  • •Planned change in immunomodulatory therapy during the study period
  • •Current need for regular self-catheterization (more than twice per week)
  • •Clinically relevant post-void residual volume, confirmed by ultrasound (>100 mL or >40% of pre-void volume)
  • •Current or past history of bladder cancer
  • •Implanted defibrillator or other pacemaker
  • •Urogenital causes of bladder dysfunction, such as stress urinary incontinence or bladder prolapse
  • •Spinal trauma within 5 years prior to study entry or any other pre-existing central nervous system disorders (e.g., stroke, Parkinson's disease), or history of pelvic, spinal, or bladder surgery
  • •Acute urinary tract infection at the time of screening or within the previous 4 weeks
  • •Urolithiasis or urogenital tumors within the past 6 months
  • •Previous electrical posterior tibial nerve stimulation (TNS), acupuncture, or acupressure in the same anatomical region within 3 months prior to study entry
  • •Regular pelvic floor training (more than twice per week) in the past 6 weeks or planned during the study period
  • •Planned participation in another interventional clinical trial during the study period
  • •Open wounds, edema, or lymphedema in the lower leg that may interfere with local intervention
  • •Other serious pre-existing conditions (e.g., active cancer, heart failure, epilepsy, etc.) that contraindicate participation in the study
  • •Obesity, defined as BMI > 30
  • •Pregnancy or breastfeeding

研究组 & 干预措施

group 1: electrical stimulation of acupuncture points plus routine care

Experimental

Intervention is electrical stimulation of two acupuncture points at the inner ankle of the foot over the posterior tibialis nerve, stimulation twice daily over 5 weeks

干预措施: group 1: electrical stimulation of acupuncture points plus routine care (Device)

group 2: acupressure plus routine care

Experimental

manual stimulation of the same two acupressure points over the inner ankle, stimulation twice daily over 5 weeks

干预措施: group 2: acupressure plus routine care (Other)

group 3: routine care alone

No Intervention

waiting list control

结局指标

主要结局

Incontinence Questionnaire Overactive Bladder (ICIQ-OAB)

时间窗: weeks 5 and 10 after the start of the intervention

Bladder function scoring 0-16, higher values mean worse outcome

次要结局

  • Incontinence Quality of Life Measure (I-QoL)(weeks 5 and 10 after the start of the intervention)
  • Patient's Global Impression of Change (PGIC)(weeks 5 and 10 after the start of the intervention)
  • 3-day voiding diary(weeks 5 and 10 after the start of the intervention)
  • 100mm Visual Analogue pain Scale (VAS) for last menstruation(at weeks 5 and 10)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benno Brinkhaus

Professor Dr. Benno Brinkhaus

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验